Back to top of page

Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)

Grant Application Information:

1. Project Title: "Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes"

2. Funding Opportunity Announcement (FOA) Number: R01

3. Clinical Trial Optional: Yes

4. Project Description: The project must integrate imaging, biomarkers, digital pathomics, glycomics, metabolomics, and other omic information and/or meta data. It should utilize platforms such as lower resolution diagnostic acquisitions and systemic biomarker results to high resolution single-cell analytics/imaging for the characterization of heterogeneous cell populations within tumors. The focus is on improving current approaches for the early detection of organ-confined premetastatic aggressive cancer and identifying precancerous lesions associated with a subsequent lethal phenotype. The project should aim to improve diagnostic uncertainty in clinical decisions by enhancing detection sensitivity and specificity through multiparametric platforms, such as N-dimensional co-registered, cross-correlated imaging data, multiplexed biomarker results, digital pathomics or glycomic, or metabolomic imaging using artificial intelligence or virtual reality visualization techniques. The project will be part of the Consortium for Imaging and Biomarkers (CIB) Research Program, with the goals of improving diagnostic performance, minimizing overdiagnosis, and reducing false positives and negatives.

5. Consortium for Imaging and Biomarkers (CIB) participation: Yes, the project will participate in the existing CIB Research Program.

6. Project Goals: The goals of the project should align with the goals of the CIB, which include:

   - Developing methodology for the early identification of potentially lethal cancer versus non-lethal disease.

   - Minimizing/better managing overdiagnosis.

   - Reducing false positives and false negatives.

Note: Additional application requirements, eligibility criteria, budget details, and submission instructions may be specified in the Funding Opportunity Announcement. Applicants should refer to the FOA for complete application guidelines.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows